Ozempic (semaglutide) is a GLP-1 receptor agonist that was specifically developed to regulate blood sugar levels in people with diabetes. In addition to its main function, positive effects on weight have been observed in some cases. However, despite promising results, it is important to emphasize that the use of Ozempic for weight loss is "off-label" and is not recommended by the BfArM.